| Net Cash Provided by (Used in) Operating Activities |
$227,800,000 |
USD |
-2.4% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$81,900,000 |
USD |
-314% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$155,200,000 |
USD |
12% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
75,520,225 |
shares |
5.4% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$29,100,000 |
USD |
48% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$48,800,000 |
USD |
45% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,300,000 |
USD |
-92% |
Q4 2024 |
FY 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$152,900,000 |
USD |
-13% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$286,500,000 |
USD |
11% |
Q3 2025 |
Q3 2025 |
| Property, Plant and Equipment, Gross |
$10,104,200,000 |
USD |
7.7% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$33,200,000 |
USD |
99% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$114,900,000 |
USD |
-22% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
25,000,000 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$2,415,000,000 |
USD |
10% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
$363,100,000 |
USD |
-9.3% |
Q4 2024 |
FY 2024 |
| Interest Expense |
$199,500,000 |
USD |
9.3% |
Q3 2025 |
Q3 2025 |